DRKS00022428已完成未知
Identification of biomarkers specific to different nicotine product categories - BoEx nicotine product user groups
ABF GmbH0 个研究点目标入组 60 人开始时间: 2020年7月20日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 60
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Non-randomized controlled study
- 盲法
- Open (masking not used)
入排标准
- 年龄范围
- 19 Years 至 65 Years（—）
- 性别
- All
入选标准
- •Subjects meeting all of the criteria listed below will be included in the clinical trial:
- •Between 19 and 65 years of age
- •Males and females
- •Physically and mentally healthy, without a legal guardian
排除标准
- •Subjects were excluded from the clinical trial without further ado if any of the following criteria were met at screening or at Day -1:
- •Dual/multiple use of any other nicotine-containing product;
- •BMI: < 18 and > 33 kg/m2;
- •Pregnant and/or lactating women;
- •Drug abusers;
- •Chronic respiratory or cardiovascular disease like asthma, chronic obstructive pulmonary disease, chronic bronchitis, hypertension (either self-reported or diagnosed by the investigator);
- •Regular use of medication, excluding hormonal contraceptives and non-prescription pain medication, prior to study inclusion within the last three months or is intended to do so during the study conduct (The definition of regular use of medication will be based on individual physician discretion).
研究者
相似试验
招募中
不适用
Identification of biomarkers for diagnosis and prognosis in the patients with obstructive sleep apneaobstructive sleep apneaJPRN-UMIN000021503Osaka university graduate School of medicine The department of geriatric and general medicine200
进行中（未招募）
不适用
Identification of genetic and functional biomarkers that predict PPAR-gamma-associated fluid retention and oedemaEUCTR2008-001634-28-GBniversity of Dundee
已完成
不适用
Identification of biomarkers which reflects the treatments effects of Nivolmab through comprehensive analyses of serum exosmal mRNA derived from the HNSCC patients.head and neck squamous cell cancerJPRN-UMIN000037029Clinical Research Support Center Kyushu111
招募中
不适用
Identification of biomarkers sensitive to disease progression in patients with Mild Cognitive Impairment. Two-Part Research: Part BF00.2Alzheimer's diseaseMild Cognitive ImpairmentF00.0F00.1F00.9F06.7Dementia in Alzheimer disease with early onsetDementia in Alzheimer disease with late onsetDementia in Alzheimer disease, atypical or mixed typeDementia in Alzheimer disease, unspecifiedMild cognitive disorderDRKS00003705QUALISSIMA150
已完成
不适用
Identification of biomarkers sensitive to disease progression in patients with Mild Cognitive Impairment: a two-part clinical study. Part A: Multisite MRI Acquisition - Protocol Harmonization Part B: Identification of biomarkers sensitive to disease progression in patients with Mild Cognitive Impairment: a clinical studyNL-OMON38870Vrije Universiteit Medisch Centrum15